Patient Guide: Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 41 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06304883
Status: ACTIVE_NOT_RECRUITING
Condition: Early Alzheimer's Disease
Phase: PHASE3

Where You Can Participate

This study is available at 41 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Sun City, Arizona
  • • Costa Mesa, California
  • • And 38 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects - Join Clinical Trial NCTNCT06304883

How to Join This Clinical Trial - NCTNCT06304883

Learn how to participate in this PHASE3 trial studying an investigational therapy for Early Alzheimer's Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Early Alzheimer's Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Early Alzheimer's Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06304883 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 41 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85004 - United States

Status: Contact for availability

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: Contact for availability

Clinical Research Site

Costa Mesa, California 92626 - United States

Status: Contact for availability

Clinical Research Site

Lomita, California 90717 - United States

Status: Contact for availability

Clinical Research Site

Sacramento, California 95816 - United States

Status: Contact for availability

Clinical Research Site

Atlantis, Florida 33462 - United States

Status: Contact for availability

Clinical Research Site

Maitland, Florida 32751 - United States

Status: Contact for availability

Clinical Research Site

Miami Beach, Florida 33140 - United States

Status: Contact for availability

Clinical Research Site

Naples, Florida 34105 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32803 - United States

Status: Contact for availability

And 31 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Early Alzheimer's Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships